Skip to content

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQ · USHealthcareBiotechnology
$28.53-2.56%

Price as of Jul 20, 2026

RARE analysis

Ultragenyx Pharmaceutical Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for RARE is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research